Jeliazko Arabadjiev: Current Systemic Options for HER2-positive Breast Cancer
Jeliazko Arabadjiev, President of the Bulgarian Scientific Society of Immuno-Oncology, shared a post on LinkedIn:
“During the 61st Oncology Congress of the Serbian Medical Society’s Oncology Section in Belgrade, I had the privilege of presenting a comprehensive review of current systemic treatment options for HER2-positive early breast cancer.
It is getting a tradition already I hope, as I was invited speaker at the last year anniversary 60th congress and now at the 61st.
Herewith would like to express my sincere gratefulness to the organisers, but mostly to my dear colleagues and friends Nada Santrac and Ivan Markovic, Associate Professor of Surgery.
Thank you to the co-moderator of the Breast Cancer Masterclass Marijana Milovic-Kovacevic for the excellent discussion and insights as well to my dear friends Ana Cvetanovic and Lazar Popovic for the warm welcome and friendship.
Looking forward already to the 62nd Oncology congress in beautiful city of Belgrade.”
For more updates, follow OncoDaily.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023